NeuroSense Therapeutics Ltd
Research NeuroSense Therapeutics Ltd (NRSN) on Bullrun: market cap USD 23.71M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNRSN
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 23.71M
- Financial periodFY2025
- Net income-USD 11.13M
- Free cash flow-USD 7.68M
Valuation Snapshot
latest market cap is USD 23.71M.
About NeuroSense Therapeutics Ltd
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally.
Frequently asked questions
What is NeuroSense Therapeutics Ltd's market cap?
NeuroSense Therapeutics Ltd's market capitalization is USD 23.71M.
What does NeuroSense Therapeutics Ltd do?
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally.